Barometer Capital Management’s TherapeuticsMD TXMD Stock Holding History

Barometer Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,498	Closed	-$539K	–	178
2019 Q3	$539K	Buy	+1,498	New	+$211K	0.06%	119
2017 Q2	–	Sell	-1,498	Closed	-$539K	–	186
2017 Q1	$539K	Buy	+1,498	New	+$464K	0.05%	119
2016 Q3	–	Sell	-1,076	Closed	-$457K	–	178
2016 Q2	$457K	Buy	+1,076	New	+$443K	0.05%	132
2015 Q3	–	Sell	-8,492	Closed	-$3.34M	–	184
2015 Q2	$3.34M	Buy	+8,492	New	+$3M	0.27%	64

Other funds holding TXMD

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barometer Capital Management's TXMD Position: Q4 2019 in Review

Barometer Capital Management sold out of TherapeuticsMD (TXMD) in Q4 2019, closing a stake of 1,498 shares — an estimated $539K sold.

Barometer Capital Management first reported a position in TXMD in Q2 2015 and held it in 4 quarters. The position peaked at $3.34M in Q2 2015. 168 funds tracked by Wall St. Rank hold TXMD as of Q4 2019.

Barometer Capital Management reported no remaining TherapeuticsMD position as of Q4 2019 after selling out during the quarter.
Barometer Capital Management sold 1,498 TherapeuticsMD shares in Q4 2019, an estimated $539K.
Barometer Capital Management first reported a position in TherapeuticsMD in Q2 2015 and held it in 4 quarters.
Barometer Capital Management's TherapeuticsMD position peaked at $3.34M in Q2 2015.
168 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2019.

Based on Barometer Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.